News | March 10, 2025
Astellas and YASKAWA to establish JV focused on cell therapy manufacturing
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
USFDA inspection at Alembic Pharma's Bioequivalence facility
Rivaroxaban Tablets USP, 2.5 mg, is bioequivalent to Xarelto® Tablets, 2.5 mg of Janssen Pharmaceuticals
This addition strengthens Dr. Agarwals Eye Hospital's vast network of 28 hospitals across Karnataka and 220+ facilities worldwide
VITADEETM Green is a 100% plant-based Vitamin D3 suitable for food & nutraceuticals
ANVIMO will be available in dosages of 240 mg and 480 mg
Melicica has potential applications in skin repair, scar and acne-prone skin care, tone evening and brightening, texture improvement, baby care, sensitive skin solutions, post-procedure recovery and stretch mark care
Carson brings with him over two decades of experience in Communications, Public Affairs, and Sustainability
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
In financial year 2024-25, PMBJP has made sales of Rs. 1,760 crore (at MRP) till Feb 2025
Subscribe To Our Newsletter & Stay Updated
